Drug General Information
Drug ID
D02ENI
Former ID
DNC004656
Drug Name
(Z)-1-(benzo[d]oxazol-2-yl)octadec-9-en-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529193]
Structure
Download
2D MOL

3D MOL

Formula
C25H37NO2
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)C1=NC2=CC=CC=C2O1
InChI
1S/C25H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23(27)25-26-22-19-17-18-21-24(22)28-25/h9-10,17-19,21H,2-8,11-16,20H2,1H3/b10-9-
InChIKey
APIPEDDJLOMNRC-KTKRTIGZSA-N
PubChem Compound ID
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529193]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.